RPG LIFE SCIENCES LTD. - 532983 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith intimation of issuance of duplicate share certificate(s) as received by us from Link Intime Private Limited, our Registrar and Share Transfer Agent, being submitted to you pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take the same on record. RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Change in Directorate
The Board has appointed Mr. Rajat Bhargava (DIN:07752438) as an Additional and Non-Executive Director of the Company. RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Adoption of revised Code of Fair Disclosure (Including Determination of Legitimate Purpose), Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Person(s) ('Code'). RPG LIFE SCIENCES LTD. - 532983 - Unaudited Financial Results For Quarter Ended December 31, 2020
Pursuant to Regulation 33 Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter and nine months ended December 31, 2020 which were approved by the Board of Directors of the Company, at its meeting held on January 25, 2021 along with Limited Review Report issued by the Statutory Auditors of the Company. RPG LIFE SCIENCES LTD. - 532983 - Outcome Of The Board Meeting Held On January 25, 2021
Outcome of the Board Meeting held on January 25, 2021 RPG LIFE SCIENCES LTD. - 532983 - Clarification On Increase In Volume
With reference to your above referred email dated January 21, 2021 seeking clarification on significant increase in the volume of security across Exchanges in the recent past, we wish to inform you that there are no events, information, announcements etc. that have a bearing on the operations/performance of the Company which includes price sensitive information, which is required to be disclosed to the stock exchanges pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Hence, we are unable to comment on the significant increase in the volume of Company's security across Exchanges, in the recent past. Further, we would like to reiterate that, as in the past, the Company would continue to inform stock exchanges regularly about any price sensitive information and to make it available on the website of the Company before the same is made public. Kindly request you to take the same on record. RPG LIFE SCIENCES LTD. - 532983 - Clarification sought from RPG Life Sciences Ltd
The Exchange has sought clarification from RPG Life Sciences Ltd on January 21, 2021, with reference to Movement in Volume.The reply is awaited. RPG LIFE SCIENCES LTD. - 532983 - Shareholding for the Period Ended December 31, 2020
RPG Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper notice published to give intimation of the meeting of Board of Directors of the Company scheduled to be held on January 25, 2021, inter alia, to consider and approve the unaudited financial results for the quarter ended December 31, 2020. Kindly take this information on record. RPG LIFE SCIENCES LTD. - 532983 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended December 31, 2020
RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2021 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Monday, January 25, 2021, inter-alia, to consider and approve the Unaudited Financial Results for the quarter ended December 31, 2020. Further, pursuant to the Code of Fair Disclosure (including Policy on determination of Legitimate Purpose) and Code of Conduct to Regulate, Monitor and Report Trading by Designated Person(s) of the Company, the Trading Window for dealing in Securities by Designated Persons and their immediate relatives, is closed from January 1, 2021 and will continue to remain closed till 48 hours after the results are made public on January 25, 2021. Kindly take this information on record.